Latest Regulatory News

Little Green Pharma has secured Federal Court approval for its full acquisition of Cannatrek, marking a key milestone in expanding its global medicinal cannabis footprint. The scheme became effective on 25 May 2026, with implementation set for 1 June.

Mt Malcolm Mines (ASX:M2M) is gearing up for a major drilling campaign at its Calypso Gold Prospect, aiming to convert a substantial Exploration Target into a JORC-compliant Mineral Resource. The program follows high-grade discoveries at the newly identified T3 Constance Lode and historical multi-lode mineralisation.

Infragreen Group Limited (ASX: IFN) forecasts a robust FY26 with underlying EBITDA rising to $22.5m-$25m and underlying NPAT surging over 270%, driven by solid performances in Energybuild and Pure Environmental. The company anticipates continued momentum into FY27, despite some short-term headwinds in Minemet and Merredin Energy.

The Takeovers Panel has refused to proceed with a disclosure dispute application related to Atlas Arteria’s off-market takeover bid and its handling of a right of first offer notice for the Chicago Skyway asset.

Thrive Tribe Technologies’ 1TTO securities face immediate suspension from ASX pending regulatory compliance, isolating the impact to this class alone amid ongoing capital raises.

Altitude Minerals has locked in a 2,300m drilling permit and contracted a rig to test high-priority copper-gold targets at its Byrock Project in NSW, with drilling set to start mid-June 2026.

Fulcrum Lithium’s Phase 3 drilling at Alkali Flats in Nevada reveals extensive, thick lithium mineralisation with grades exceeding 300ppm across a large area, setting the stage for a maiden Mineral Resource Estimate.

Nickel Industries has boosted the Sampala Project’s nickel resource to over 1 billion tonnes, reinforcing its position among the world’s largest nickel laterite holders and advancing development with a $144 million acquisition payment due next year.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

Delorean’s flagship SA1 Salisbury bioenergy plant is 75% complete, poised to start injecting renewable biomethane into Adelaide’s gas network by November 2026, marking a first in Australia for commercial and industrial organic waste processing.

Electro Optic Systems (ASX:EOS) invites eligible shareholders to participate in a capped A$25 million Share Purchase Plan at the same price as its recent A$150 million institutional placement, supporting its MARSS acquisition and growth strategy.

NoviqTech Limited attributes its recent share price jump and trading volume spike to earlier announcements about pivotal biochar trials and a major carbon removal offtake by Lufthansa Group, affirming its compliance with ASX rules.